(44.201.99.222)
Users online: 1735    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2017, Volume : 10, Issue : 5
First page : ( 1571) Last page : ( 1576)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2017.00276.1

Graphene Mediated Drug Delivery-A Boon to Cancer Therapy

Deb Ananya1, Vimala R2,*

1School of Biosciences and Technology, VIT University, Vellore-632014, Tamilnadu, India

2Center for Nanotechnology Research, VIT University, Vellore-632014, Tamilnadu, India

*Corresponding Author E-mail: vimararagu@gmail.com

Online published on 17 July, 2017.

Abstract

Graphene which is an allotrope of carbon has become focus of attention due to its unique 2-D structure, and exceptional physio-chemical properties. It has been established to have a wide range of application in the nanomedicine and biomedical field. Recently graphene and the other members of the family including graphene oxide (GO) and reduced GO (rGO) have emerged as a novel and competitive drug delivery system. Graphene has been functionalized with different conjugates like polyethylene glycol (PEG), polyvinyl pyrolidone (PVP), folic acid (FA) and ammonia (NH2) to enhance its solubility and biocompatibility. When combined with anticancer drugs, graphene and its derivatives have been reported to increase the efficacy of the drug simultaneously reducing its side effects. Herein we present a summary of the studies carried out using graphene and its conjugates in the field of drug delivery and cancer therapy.

Top

Keywords

Biocompatible, cancer therapy, drug delivery, graphene, polyethylene glycol.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
597,048,879 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.